Journal of Molecular and Cellular Cardiology
Volume 49, Issue 5 , Pages 715-718 , November 2010

Static and dynamic properties of the HCM myocardium

Received 15 July 2010 ,Accepted 25 July 2010.

References 

  1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270–276
  2. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363:1881–1891
  3. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308–1320
  4. Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation. 1996;94:850–856
  5. Xu Q, Dewey S, Nguyen S, Gomes AV. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes. J Mol Cell Cardiol. 2010;48:899–909
  6. Maron BJ, Sato N, Roberts WC, Edwards JE, Chandra RS. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy. Circulation. 1979;60:685–696
  7. Hoskins AC, Jacque B, Bardswell SC, McKenna WJ, Tsang V, Dos Remedios CG, et al. Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2010;49:737–745
  8. Noble MI. The diastolic viscous properties of cat papillary muscle. Circ Res. 1977;40:288–292
  9. Chiu YL, Ballou EW, Ford LE. Internal viscoelastic loading in cat papillary muscle. Biophys J. 1982;40:109–120
  10. Chiu YL, Ballou EW, Ford LE. Velocity transients and viscoelastic resistance to active shortening in cat papillary muscle. Biophys J. 1982;40:121–128
  11. Minajeva A, Kulke M, Fernandez JM, Linke WA. Unfolding of titin domains explains the viscoelastic behavior of skeletal myofibrils. Biophys J. 2001;80:1442–1451
  12. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002;105:1387–1393
  13. Stuyvers BD, Miura M, ter Keurs HE. Dynamics of viscoelastic properties of rat cardiac sarcomeres during the diastolic interval: involvement of Ca2+. J Physiol. 1997;502(Pt 3):661–677
  14. LeWinter MM, Wu Y, Labeit S, Granzier H. Cardiac titin: structure, functions and role in disease. Clin Chim Acta. 2007;375:1–9
  15. Labeit S, Kolmerer B, Linke WA. The giant protein titin. Emerging roles in physiology and pathophysiology. Circ Res. 1997;80:290–294
  16. Borbely A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, Gavina C, et al. Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res. 2009;104:780–786
  17. Wang X, Li F, Campbell SE, Gerdes AM. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: II Cytoskeletal remodeling. J Mol Cell Cardiol. 1999;31:319–331
  18. Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, Greaser M, et al. PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res. 2009;105:631–638
  19. Kruger M, Linke WA. Titin-based mechanical signalling in normal and failing myocardium. J Mol Cell Cardiol. 2009;46:490–498
  20. Tagawa H, Wang N, Narishige T, Ingber DE, Zile MR, Gt Cooper. Cytoskeletal mechanics in pressure-overload cardiac hypertrophy. Circ Res. 1997;80:281–289
  21. Yamamoto S, Tsutsui H, Takahashi M, Ishibashi Y, Tagawa H, Imanaka-Yoshida K, et al. Role of microtubules in the viscoelastic properties of isolated cardiac muscle. J Mol Cell Cardiol. 1998;30:1841–1853
  22. Fujita H, Labeit D, Gerull B, Labeit S, Granzier HL. Titin isoform-dependent effect of calcium on passive myocardial tension. Am J Physiol Heart Circ Physiol. 2004;287:H2528–H2534
  23. Wu Y, Tobias AH, Bell K, Barry W, Helmes M, Trombitas K, et al. Cellular and molecular mechanisms of systolic and diastolic dysfunction in an avian model of dilated cardiomyopathy. J Mol Cell Cardiol. 2004;37:111–119
  24. Thai HM, Van HT, Gaballa MA, Goldman S, Raya TE. Effects of AT1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility. Am J Physiol. 1999;276:H873–H880
  25. Lopez MA, Mayer U, Hwang W, Taylor T, Hashmi MA, Jannapureddy SR, et al. Force transmission, compliance, and viscoelasticity are altered in the alpha7-integrin-null mouse diaphragm. Am J Physiol Cell Physiol. 2005;288:C282–C289
  26. Jannapureddy SR, Patel ND, Hwang W, Boriek AM. Genetic models in applied physiology. Merosin deficiency leads to alterations in passive and active skeletal muscle mechanics. J Appl Physiol. 2003;94:2524–2533discussion 3
  27. Bronzwaer JG, Paulus WJ. Matrix, cytoskeleton, or myofilaments: which one to blame for diastolic left ventricular dysfunction?. Prog Cardiovasc Dis. 2005;47:276–284
  28. van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JM, Winegrad S, et al. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation. 2009;119:1473–1483
  29. Kerrick WG, Kazmierczak K, Xu Y, Wang Y, Szczesna-Cordary D. Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice. FASEB J. 2009;23:855–865
  30. Gomes AV, Potter JD. Molecular and cellular aspects of troponin cardiomyopathies. Ann NY Acad Sci. 2004;1015:214–224
  31. Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res. 2008;77:659–666
  32. van der Velden J, Papp Z, Zaremba R, Boontje NM, de Jong JW, Owen VJ, et al. Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res. 2003;57:37–47
  33. Hamdani N, Kooij V, van Dijk S, Merkus D, Paulus WJ, Remedios CD, et al. Sarcomeric dysfunction in heart failure. Cardiovasc Res. 2008;77:649–658
  34. El-Armouche A, Pohlmann L, Schlossarek S, Starbatty J, Yeh YH, Nattel S, et al. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J Mol Cell Cardiol. 2007;43:223–229
  35. Gomes AV, Harada K, Potter JD. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin. J Mol Cell Cardiol. 2005;39:754–765
  36. Huke S, Bers DM. Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes. Biochem Biophys Res Commun. 2008;376:80–85
  37. Hofmann PA, Hartzell HC, Moss RL. Alterations in Ca2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers. J Gen Physiol. 1991;97:1141–1163
  38. Kulikovskaya I, McClellan G, Levine R, Winegrad S. Effect of extraction of myosin binding protein C on contractility of rat heart. Am J Physiol Heart Circ Physiol. 2003;285:H857–H865
  39. Cazorla O, Szilagyi S, Le Guennec JY, Vassort G, Lacampagne A. Transmural stretch-dependent regulation of contractile properties in rat heart and its alteration after myocardial infarction. FASEB J. 2005;19:88–90
  40. Maron BJ, Anan TJ, Roberts WC. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation. 1981;63:882–894
  41. Sengupta PP, Mehta V, Arora R, Mohan JC, Khandheria BK. Quantification of regional nonuniformity and paradoxical intramural mechanics in hypertrophic cardiomyopathy by high frame rate ultrasound myocardial strain mapping. J Am Soc Echocardiogr. 2005;18:737–742
  42. Ganame J, Mertens L, Eidem BW, Claus P, D'Hooge J, Havemann LM, et al. Regional myocardial deformation in children with hypertrophic cardiomyopathy: morphological and clinical correlations. Eur Heart J. 2007;28:2886–2894
  43. Kato TS, Izawa H, Komamura K, Noda A, Asano H, Nagata K, et al. Heterogeneity of regional systolic function detected by tissue Doppler imaging is linked to impaired global left ventricular relaxation in hypertrophic cardiomyopathy. Heart. 2008;94:1302–1306
  44. Dong SJ, MacGregor JH, Crawley AP, McVeigh E, Belenkie I, Smith ER, et al. Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study. Circulation. 1994;90:1200–1209

PII: S0022-2828(10)00281-6

doi: 10.1016/j.yjmcc.2010.07.016

Journal of Molecular and Cellular Cardiology
Volume 49, Issue 5 , Pages 715-718 , November 2010

Article Tools